scholarly journals Effects of Whole-Body Vibration Therapy in Patients with Fibromyalgia: A Systematic Literature Review

2015 ◽  
Vol 2015 ◽  
pp. 1-11 ◽  
Author(s):  
Daniel Collado-Mateo ◽  
Jose C. Adsuar ◽  
Pedro R. Olivares ◽  
Borja del Pozo-Cruz ◽  
Jose A. Parraca ◽  
...  

Objective. To review the literature on the effects of whole-body vibration therapy in patients with fibromyalgia.Design. Systematic literature review.Patients. Patients with fibromyalgia.Methods. An electronic search of the literature in four medical databases was performed to identify studies on whole-body vibration therapy that were published up to the 15th of January 2015.Results. Eight articles satisfied the inclusion and exclusion criteria and were analysed. According to the Dutch CBO guidelines, all selected trials had a B level of evidence. The main outcomes that were measured were balance, fatigue, disability index, health-related quality of life, and pain. Whole-body vibration appeared to improve the outcomes, especially balance and disability index.Conclusion. Whole-body vibration could be an adequate treatment for fibromyalgia as a main therapy or added to a physical exercise programme as it could improve balance, disability index, health-related quality of life, fatigue, and pain. However, this conclusion must be treated with caution because the paucity of trials and the marked differences between existing trials in terms of protocol, intervention, and measurement tools hampered the comparison of the trials.

2021 ◽  
Vol 13 (5) ◽  
pp. 2581
Author(s):  
Francisco J. Domínguez-Muñoz ◽  
Jorge Carlos-Vivas ◽  
Miguel A. Garcia-Gordillo ◽  
Santos Villafaina ◽  
Fernando Pérez-Escanilla ◽  
...  

Background: Type 2 diabetes mellitus (T2DM) is a chronic disorder, with patients exhibiting hyperglycemia in fasting and postprandial states. T2DM has several complications, including loss of sensation in more distal body parts. Good peripheral sensitivity is essential as this affects different parameters related to activities of daily living, such as leg strength and balance. The objectives of this project were to assess the effects of an 8-week whole-body vibration (WBV) training program on (1) vibration perception threshold (VPT), (2) balance, (3) strength, (4) lipidic profile, (5) health-related quality of life, (6) diabetic neuropathy, and (7) body composition in T2DM patients. Methods/Design: A double-blind, randomized controlled study, with WBV and placebo groups, was carried out. Both groups performed 8 weeks of intervention, with 3 sessions per week, completing a total of 24 sessions. There were two groups: the experimental group, i.e., the WBV group, who received WBV therapy; and the placebo group, who completed a simulated training program that was developed on a Galileo Fitness platform, connected to software displayed on a screen. The participant could see the parameters of the simulated vibration training (duration, amplitude, and frequency), but it was the software that controlled the speakers placed inside the vibration platform. Ninety patients with T2DM (56 males and 34 females) were recruited for the intervention. Participants were assigned equally to the WBV (n = 45) and placebo (n = 45) groups. Primary outcome measures were (1) HbA1c and (2) vibration threshold. Secondary measures were (1) health-related quality of life, (2) balance, (3) strength, (4) body composition, (5) blood pressure, (6) diabetic neuropathy, and (7) lipidic profile. Statistical analysis was carried out by treatment intention and protocol. Discussion: This project aimed to investigate the effects of WBV training on HbA1c, vibration threshold, and incremental cost-effectiveness ratio in T2DM patients. In future, guidelines will be provided for the incorporation of the main obtained conclusions into the social-sanitary system and businesses.


2005 ◽  
Vol 86 (2) ◽  
pp. 303-307 ◽  
Author(s):  
Olivier Bruyere ◽  
Marc-Antoine Wuidart ◽  
Elio Di Palma ◽  
Margaret Gourlay ◽  
Olivier Ethgen ◽  
...  

Seizure ◽  
2009 ◽  
Vol 18 (8) ◽  
pp. 554-558 ◽  
Author(s):  
Katy Gallop ◽  
Diane Wild ◽  
Annabel Nixon ◽  
Lara Verdian ◽  
Joyce A. Cramer

2019 ◽  
Vol 122 ◽  
pp. 252-265 ◽  
Author(s):  
Virendra R. Desai ◽  
Nisha Gadgil ◽  
Shahbaz Saad ◽  
Jeffrey S. Raskin ◽  
Sandi K. Lam

2021 ◽  
Vol 8 (2) ◽  
pp. 36-45
Author(s):  
Christina Soeun Kwon ◽  
Patrick Daniele ◽  
Anna Forsythe ◽  
Christopher Ngai

Introduction: This systematic literature review analyzed published evidence on IgA nephropathy (IgAN), focusing on US epidemiology, health-related quality of life (HRQoL), and economic burden of illness. Methods: Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, Embase®, MEDLINE®, Cochrane, and Econlit (January 2010 to June 2020) were searched, along with relevant congresses (2017-2020). Results: Of 123 epidemiologic studies selected for data extraction, 24 reported IgAN diagnosis rates ranging from 6.3% to 29.7% among adult and pediatric patients undergoing renal biopsy, with all reported US rates <15%. No US studies reported IgAN prevalence. A meta-analysis of US studies calculated an annual incidence of 1.29/100 000 people, translating to an annual US incidence of 4236 adults and children. Relative to Europe, the United States had more patients diagnosed with IgAN in later chronic kidney disease stages. US rates of transition to end-stage renal disease (ESRD) ranged from 12.5% to 23% during 3-3.9 years of observation, rising to 53% during 19 years of observation. Across 8 studies reporting HRQoL, pain and fatigue were the most reported symptoms, and patients consistently ranked kidney function and mortality as the most important treatment outcomes. Patients with glomerulopathy reported worse mental health than healthy controls or hemodialysis patients; proteinuria was significantly associated with poorer HRQoL and depression. Conclusion: While economic evidence in IgAN remains sparse, management of ESRD is a major cost driver. IgAN is a rare disease where disease progression causes increasing patient burden, underscoring the need for therapies that prevent kidney function decline and HRQoL deterioration while reducing mortality.


2015 ◽  
Vol 18 (1) ◽  
pp. 7 ◽  
Author(s):  
Taís De Souza Barbosa ◽  
Maria Beatriz Duarte Gavião ◽  
Fábio Luiz Mialhe

<p><strong>Objective:</strong> The aim of this study was to review the literature about the relationship between gingivitis and oral health-related quality of life (OHRQoL). <strong>Material and methods:</strong> Relevant databases were searched for articles in English, which had been published from October 1990 to February 2014. Two independent examiners selected relevant papers, by initially assessing the abstracts and subsequently the full-text articles. Selected studies were grouped based on clinical and OHRQoL instruments and submitted to qualitative analyses. <strong>Results:</strong> Out of 184 references, twelve were eligible for synthesis. All studies were cross-sectional and reported data from the following five different countries: Chile (n=2), India (n=1), Brazil (n=3), Thailand (n=5) and Sudan (n=1). The number and age of subjects included ranged from 53 to 9133 and from eight to 106 years, respectively. The following six OHRQoL instruments were used: Oral Health Impact Profile (OHIP), OHIP-14, Child Perceptions Questionnaire (CPQ), Oral Impacts on Daily Performance (OIDP), Child-OIDP and Geriatric Oral Health Assessment Index (GOHAI). The different methods to evaluate the presence of gingivitis were: necrotizing ulcerative gingival lesions (n=2), Gingival Index (n=2), Community Periodontal Index (n=7) and gingival bleeding after tooth brushing (n=1). <strong>Conclusion:</strong> This literature review suggests that gingivitis is associated with impairment of OHRQoL. </p>


Sign in / Sign up

Export Citation Format

Share Document